A retrospective study of treatment outcomes of programmed death-1 (PD-1) inhibitors or chemotherapy in advanced gastric cancer patients
Latest Information Update: 23 Nov 2021
At a glance
- Drugs Irinotecan (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
Most Recent Events
- 23 Nov 2021 New trial record